Skip to content
(RS)-pimobendan

Structure via PubChem · Public domain (PubChem)

EntityQ414351· pop 12· linked from 172 articles

(RS)-pimobendan

Sign in to save

Also known as DL-pimobendan, pimobendan, pimobendane

Pimobendan (INN, or pimobendane), sold under the brand name Vetmedin among others, is a veterinary medication. It is a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3) with positive inotropic and vasodilator effects.

Key facts

Drug.Verifiedfields
changed
Drug.Watchedfields
changed
Drug.verifiedrevid
408556559
Drug.image
Pimobendan skeletal.svg
Drug.image_class
skin-invert-image
Drug.width
200
Drug.image2
Pimobendan.jpg
Drug.chirality
Racemic mixture
Drug.tradename
Vetmedin, others
Drug.DailyMedID
Pimobendan
Drug.routes_of_administration
By mouth
Drug.class
Calcium sensitizer
Drug.ATCvet
yes
Drug.ATC_prefix
C01
Drug.ATC_suffix
CE90
Drug.legal_US
Rx-only
Drug.legal_status
Rx-only
Drug.bioavailability
60 to 65%

via Wikipedia infobox

Chemical data

Formula
C19H18N4O2
Molecular weight
334.4 g/mol
IUPAC name
3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one
SMILES
CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
InChIKey
GLBJJMFZWDBELO-UHFFFAOYSA-N
XLogP
2.7
Polar surface area
79.4 Ų
H-bond donors
2
H-bond acceptors
4
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Mass
334.143
Show 5 more facts
chemical formula
C₁₉H₁₈N₄O₂
canonical SMILES
CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
World Health Organisation international non-proprietary name
pimobendan
Commons category
Pimobendan
Sources (2)

via Wikidata · CC0

~5 min read

Encyclopedic overview

7 sections
Contents
  • Medical uses
  • Mechanism of action
  • Pharmacokinetics
  • Combinations
  • Synthesis
  • References
  • Further reading

Pimobendan (INN, or pimobendane), sold under the brand name Vetmedin among others, is a veterinary medication. It is a calcium sensitizer and a selective inhibitor of phosphodiesterase 3 (PDE3) with positive inotropic and vasodilator effects.

Pimobendan is used in the management of heart failure in dogs, most commonly caused by myxomatous mitral valve disease (also previously known as endocardiosis), or dilated cardiomyopathy. Research has shown that as a monotherapy, pimobendan increases survival time and improves quality of life in canine patients with congestive heart failure secondary to mitral valve disease when compared with benazepril, an ACE inhibitor. Under the brand name Acardi, it is available for human use in Japan. It is available as a generic medication.

Excerpted from Wikipedia’s “(RS)-pimobendan” article, available under the CC BY-SA 4.0 licence.

Gallery (2)

Available in 11 languages

via Wikidata sitelinks · CC0